SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Tyler N. Starr(University of Utah), Gyorgy Snell(VIR Biotechnology (United States))
Cited by 582
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
|Science Translational Medicine|2022|118
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
|PLoS Pathogens|2022|80